tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Rigel Pharmaceuticals raises FY25 revenue view to $285M-$290M from $270M-$280M

Consensus is for FY25 revenue $281.09M. Sees FY25 Net product sales $225M-$230M, an increase from the previous range of $210M-$220M; and contract revenues from collaborations of approximately $60M.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1